pitolisant hydrochloride


( Last Updated : November 10, 2021)
Generic Name:
pitolisant hydrochloride
Project Status:
Pending
Therapeutic Area:
Narcolepsy
Manufacturer:
Paladin Labs Inc.
Call for patient/clinician input open:
Brand Name:
Wakix
Project Line:
Reimbursement Review
Project Number:
SR0715-000
Call for patient/clinician input closed:

Details


Manufacturer Requested Reimbursement Criteria1:
Paladin Labs Inc. is requesting for Wakix (pitolisant hydrochloride tablets) to be reimbursed for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy.
Submission Type:
Initial
Fee Schedule:
Pending
Indications:
Wakix (pitolisant hydrochloride tablets) is indicated for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy.
Anticipated Date:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.